Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

LFST vs RNW: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

RNW Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 8–2 Matrix Metrics)

RNW Overall Winner 6-Pillar Tally: LFST 1 – 5 RNW Matrix Metrics: LFST 2 – 8 RNW

As of Nov 20, 2026, ReNew Energy Global plc Class A (RNW) is the stronger overall head-to-head candidate over LifeStance Health Group, Inc. (LFST) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). LFST carries a Unified Composite Score of 36.9/100 (SELL) at $13.82 (30.8x Forward P/E, 6.4% operating margin), whereas RNW carries 55.6/100 (HOLD) at $6.88 (30.3x Forward P/E, 46.7% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About LFST vs RNW
LFST NASDAQ
LifeStance Health Group, Inc. Common Stock
Services-Health Services
$13.82
+3.6% 1D
Market Cap $5.1B
TTM Revenue $1.68B
Forward P/E 30.8x
Beta / 30D Vol 0.68β · 45% Vol
Unified Composite Score
36.9 / 100 SELL
Tech 38.0 Fund 35.0 Flow 50.0 Mom 11.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (4.0% over 20 days), RSI 54
RSI-14: 53.6 · SMA20: $13.80 · SMA50: $12.90
RNW NASDAQ Head-to-Head Winner
ReNew Energy Global plc Class A Ordinary Shares
Electric Services
$6.88
-0.58% 1D
Market Cap $2.5B
TTM Revenue $1.65B
Forward P/E 30.3x
Beta / 30D Vol 0.60β · 4% Vol
Unified Composite Score
55.6 / 100 HOLD
Tech 43.0 Fund 52.0 Flow 54.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 41
RSI-14: 41.3 · SMA20: $6.92 · SMA50: $6.88

6-Pillar Scorecard Institutional Category Breakdown (LFST 1 – 5 RNW)

Columns: Metric · LFST · RNW
1. Valuation Multiples RNW
Forward P/E 30.8x 30.3x
Trailing P/E 74.1x 18.2x
PEG Ratio N/M N/M
EV / Revenue 3.0x 6.9x
2. Growth & Scale RNW
Revenue Growth (YoY) +25.3% +28.2%
Earnings Growth (YoY) N/A +42.5%
TTM Revenue (USD) $1.68B $1.65B
Market Cap $5.1B $2.5B
3. Profitability & Quality RNW
Gross Margin 34.4% 82.1%
Operating Margin 6.4% 46.7%
Net Profit Margin 4.3% 8.4%
Return on Equity (ROE) 4.8% 8.6%
4. Balance Sheet & Cash Flow LFST
Cash Generation (TTM) $164M EBITDA -$42M
Cash Flow Margin 9.8% EBITDA Mgn -2.6%
Net Cash / Leverage $3.92 Book/Sh · 4.8% ROE $8.89B Net Debt (5.82x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning RNW
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile 42.6% (50th %ile) 0.3% (<1st %ile)
Put/Call OI Skew N/A 0.02x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Neutral
6. R&D & Supply-Chain Moat RNW
OpEx & R&D Intensity 28.0% of Rev ($470M) 35.4% of Rev ($585M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning High-Margin Pricing Power Moat
Supply-Chain Role Medical Care Facilities Operator Utilities - Renewable Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: LFST (2) vs RNW (8)
Institutional Metric LFST RNW Criterion Row Edge
Market Capitalization
Scale
$5.1B $2.5B Larger Scale LFST
Trailing P/E Ratio
Valuation
74.1x 18.2x Lower Multiple RNW
Forward P/E Ratio
Valuation
30.8x 30.3x Lower Multiple RNW
Revenue Growth (YoY)
Growth
+25.3% +28.2% Higher Growth RNW
Operating Margin (TTM)
Profitability
6.4% 46.7% Higher Margin RNW
Net Profit Margin
Profitability
4.3% 8.4% Higher Margin RNW
Return on Equity (ROE)
Capital Efficiency
4.8% 8.6% Higher ROE RNW
52-Week Range Position
Momentum
81% ($6–$16) 76% ($4–$8) Stronger Trend LFST
Beta / 30D Volatility
Risk Regime
0.68β · 45% Vol 0.60β · 4% Vol Lower Realized Risk RNW
Unified Institutional Score
Composite Signal
36.9 / 100 (SELL) 55.6 / 100 (HOLD) Higher Composite RNW
Trailing 12M Revenue (USD)
Operating Scale
$1.68B $1.65B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
34.4% 82.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 3.0x EV/Rev N/M PEG · 6.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$164M EBITDA ($3.92 Book/Sh · 4.8% ROE) -$42M ($8.89B Net Debt (5.82x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon LFST +10.03 pp
LFST: +10.03% · RNW: +0.0%
3M Horizon LFST +12.47 pp
LFST: +13.65% · RNW: +1.18%
6M Horizon LFST +70.79 pp
LFST: +87.01% · RNW: +16.22%
1Y Horizon LFST +132.13 pp
LFST: +123.62% · RNW: -8.51%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on LFST vs RNW. Trailing 12-month operating profitability (LFST 6.4% vs RNW 46.7%) and valuation multiples (LFST 30.8x vs RNW 30.3x Forward P/E) are benchmarked directly in Pillar 4 below.

LFST ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.68B
Gross Margin34.4%
Op. Margin6.4%
ROE / Fwd P/E4.8% · 30.8x
RNW ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.65B
Gross Margin82.1%
Op. Margin46.7%
ROE / Fwd P/E8.6% · 30.3x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
LFST UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 42.6%
IV Percentile 50th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact LFST Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
RNW CONSOLIDATION
121d in phase · OBV NEUTRAL
Current IV 0.3%
IV Percentile <1st %ile
Put/Call OI Skew 0.02x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact RNW Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
LFST Moat Profile Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $5.1B market capitalization and 6.4% operating margin.
OpEx & R&D Reinvestment 28.0% of Rev ($470M)
90D Engineering Disclosures 0 Published
RNW Moat Profile High-Margin Pricing Power Moat
Utilities - Renewable Operator
Competes within the Utilities - Renewable value chain with $2.5B market capitalization and 46.7% operating margin.
OpEx & R&D Reinvestment 35.4% of Rev ($585M)
90D Engineering Disclosures 0 Published

Investor FAQ LFST vs RNW Key Questions & Quantitative Answers

As of Nov 20, 2026, ReNew Energy Global plc Class A (RNW) is the stronger overall head-to-head candidate over LifeStance Health Group, Inc. (LFST) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). LFST carries a Unified Composite Score of 36.9/100 (SELL) at $13.82 (30.8x Forward P/E, 6.4% operating margin), whereas RNW carries 55.6/100 (HOLD) at $6.88 (30.3x Forward P/E, 46.7% operating margin). Technically, LFST sits in a Markup phase (RSI 53.6, UNCLASSIFIED options structure) and RNW sits in a Neutral phase (RSI 41.3, CONSOLIDATION options structure).

RNW leads the Growth & Scale pillar: LFST posts +25.3% YoY revenue growth and N/A YoY earnings growth on $1.68B TTM revenue (34.4% gross margin, 6.4% operating margin), compared with RNW at +28.2% YoY revenue growth and +42.5% YoY earnings growth on $1.65B TTM revenue (82.1% gross margin, 46.7% operating margin). On trailing 12-month operating scale, LFST generates $1.68B in USD-normalized revenue versus $1.65B for RNW. In operating R&D and SG&A reinvestment, LFST deploys 28.0% of Rev ($470M) (0 90-day corporate R&D disclosures) versus 35.4% of Rev ($585M) (0 disclosures) for RNW.

RNW screens cheaper on headline valuation multiples. LFST trades at 30.8x Forward P/E, 74.1x Trailing P/E, N/M PEG, and 3.0x EV/Revenue (9.8% EBITDA margin), whereas RNW trades at 30.3x Forward P/E, 18.2x Trailing P/E, N/M PEG, and 6.9x EV/Revenue (-2.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against LFST (4.8% ROE) versus RNW (8.6% ROE) capital efficiency.

In options market volatility and institutional positioning, LFST carries 42.6% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.68β · 45% Vol realized risk). By comparison, RNW carries 0.3% implied volatility (<1st %ile, Compressed (<25th %ile)), a 0.02x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.60β · 4% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.